Bamlanivimab + Etesevimab Reduces SARS - CoV - 2 Viral Load

No significant reduction seen in viral load at day 11 with bamlanivimab monotherapy in mild - to - moderate COVID - 19
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Infections, Nursing, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news